Pathstone Holdings’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
48,209
+23,188
| +93% | +$835K | 0.01% | 1082 |
|
|
2025
Q1 | $779K | Buy |
25,021
+14,980
| +149% | +$466K | ﹤0.01% | 1505 |
|
|
2024
Q4 | $256K | Sell |
10,041
-11,965
| -54% | -$305K | ﹤0.01% | 2042 |
|
|
2024
Q3 | $623K | Buy |
22,006
+2,467
| +13% | +$69.8K | ﹤0.01% | 1620 |
|
|
2024
Q2 | $515K | Buy |
19,539
+76
| +0.4% | +$2K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $591K | Buy |
19,463
+6,971
| +56% | +$212K | ﹤0.01% | 1597 |
|
|
2023
Q4 | $352K | Buy |
+12,492
| New | +$352K | ﹤0.01% | 1717 |
|